Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089)
China · Delayed Price · Currency is CNY 21.49
-0.19 (-0.88%)
At close: Jun 11, 2026
SHE:301089 Revenue
Tuoxin Pharmaceutical Group had revenue of 92.50M CNY in the quarter ending March 31, 2026, a decrease of -4.63%. This brings the company's revenue in the last twelve months to 373.85M, down -8.90% year-over-year. In the year 2025, Tuoxin Pharmaceutical Group had annual revenue of 378.34M, down -10.28%.
Revenue (ttm)
373.85M
Revenue Growth
-8.90%
P/S Ratio
7.34
Revenue / Employee
242.29K
Employees
1,543
Market Cap
2.74B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 378.34M | -43.35M | -10.28% |
| Dec 31, 2024 | 421.69M | -413.82M | -49.53% |
| Dec 31, 2023 | 835.51M | 50.79M | 6.47% |
| Jan 1, 2023 | 784.72M | 282.24M | 56.17% |
| Jan 1, 2022 | 502.48M | -25.46M | -4.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Anhui Fengyuan Pharmaceutical | 3.86B |
| Guizhou Yibai Pharmaceutical | 1.72B |
| Shaanxi Panlong Pharmaceutical Group | 1.11B |
| Anhui Sunhere Pharmaceutical Excipients | 956.32M |
| ShanXi C&Y Pharmaceutical Group Co.,LTD. | 862.85M |
| Jiangxi Synergy Pharmaceutical | 826.15M |
| Baotou Dongbao Bio-Tech Co.,Ltd | 747.80M |
| Hainan Huluwa Pharmaceutical Group | 710.14M |